sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Parkinson’s Disease Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Parkinson’s Disease Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :119
Published Date : 2020-12-28

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Parkinson’s Disease Drugs Market with our analysts monitoring the situation across the globe.
Parkinson’s Disease Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson’s Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2027. Segment by Type, the Parkinson’s Disease Drugs market is segmented into Oral Transdermal Subcutaneous Intestinal Infusion Segment by Application, the Parkinson’s Disease Drugs market is segmented into Hospital Pharmacy Retail Pharmacy Online Pharmacy Regional and Country-level Analysis The Parkinson’s Disease Drugs market is analysed and market size information is provided by regions (countries). The key regions covered in the Parkinson’s Disease Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2027. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2027. Competitive Landscape and Parkinson’s Disease Drugs Market Share Analysis Parkinson’s Disease Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2021. Details included are company description, major business, company total revenue and the sales, revenue generated in Parkinson’s Disease Drugs business, the date to enter into the Parkinson’s Disease Drugs market, Parkinson’s Disease Drugs product introduction, recent developments, etc. The major vendors covered: Novartis F. Hoffmann-La Roche AbbVie Teva Pharmaceutical Industries UCB Inc. STADA Arzneimittel GlaxoSmithKline Bausch Health Merck Impax Laboratories
1 Study Coverage 1.1 Parkinson’s Disease Drugs Product Introduction 1.2 Market Segments 1.3 Key Parkinson’s Disease Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Parkinson’s Disease Drugs Market Size Growth Rate by Type 1.4.2 Oral 1.4.3 Transdermal 1.4.4 Subcutaneous 1.4.5 Intestinal Infusion 1.5 Market by Application 1.5.1 Global Parkinson’s Disease Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacy 1.5.3 Retail Pharmacy 1.5.4 Online Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Parkinson’s Disease Drugs Market Size, Estimates and Forecasts 2.1.1 Global Parkinson’s Disease Drugs Revenue 2015-2027 2.1.2 Global Parkinson’s Disease Drugs Sales 2015-2027 2.2 Global Parkinson’s Disease Drugs, Market Size by Producing Regions: 2015 VS 2021 VS 2027 2.2.1 Global Parkinson’s Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2021 2.2.2 Global Parkinson’s Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2021 3 Global Parkinson’s Disease Drugs Competitor Landscape by Players 3.1 Parkinson’s Disease Drugs Sales by Manufacturers 3.1.1 Parkinson’s Disease Drugs Sales by Manufacturers (2015-2021) 3.1.2 Parkinson’s Disease Drugs Sales Market Share by Manufacturers (2015-2021) 3.2 Parkinson’s Disease Drugs Revenue by Manufacturers 3.2.1 Parkinson’s Disease Drugs Revenue by Manufacturers (2015-2021) 3.2.2 Parkinson’s Disease Drugs Revenue Share by Manufacturers (2015-2021) 3.2.3 Global Parkinson’s Disease Drugs Market Concentration Ratio (CR5 and HHI) (2015-2021) 3.2.4 Global Top 10 and Top 5 Companies by Parkinson’s Disease Drugs Revenue in 2019 3.2.5 Global Parkinson’s Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Parkinson’s Disease Drugs Price by Manufacturers 3.4 Parkinson’s Disease Drugs Manufacturing Base Distribution, Product Types 3.4.1 Parkinson’s Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Parkinson’s Disease Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Parkinson’s Disease Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2027) 4.1 Global Parkinson’s Disease Drugs Market Size by Type (2015-2021) 4.1.1 Global Parkinson’s Disease Drugs Sales by Type (2015-2021) 4.1.2 Global Parkinson’s Disease Drugs Revenue by Type (2015-2021) 4.1.3 Parkinson’s Disease Drugs Average Selling Price (ASP) by Type (2015-2027) 4.2 Global Parkinson’s Disease Drugs Market Size Forecast by Type (2021-2027) 4.2.1 Global Parkinson’s Disease Drugs Sales Forecast by Type (2021-2027) 4.2.2 Global Parkinson’s Disease Drugs Revenue Forecast by Type (2021-2027) 4.2.3 Parkinson’s Disease Drugs Average Selling Price (ASP) Forecast by Type (2021-2027) 4.3 Global Parkinson’s Disease Drugs Market Share by Price Tier (2015-2021): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2027) 5.1 Global Parkinson’s Disease Drugs Market Size by Application (2015-2021) 5.1.1 Global Parkinson’s Disease Drugs Sales by Application (2015-2021) 5.1.2 Global Parkinson’s Disease Drugs Revenue by Application (2015-2021) 5.1.3 Parkinson’s Disease Drugs Price by Application (2015-2021) 5.2 Parkinson’s Disease Drugs Market Size Forecast by Application (2021-2027) 5.2.1 Global Parkinson’s Disease Drugs Sales Forecast by Application (2021-2027) 5.2.2 Global Parkinson’s Disease Drugs Revenue Forecast by Application (2021-2027) 5.2.3 Global Parkinson’s Disease Drugs Price Forecast by Application (2021-2027) 6 North America 6.1 North America Parkinson’s Disease Drugs by Country 6.1.1 North America Parkinson’s Disease Drugs Sales by Country 6.1.2 North America Parkinson’s Disease Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Parkinson’s Disease Drugs Market Facts & Figures by Type 6.3 North America Parkinson’s Disease Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Parkinson’s Disease Drugs by Country 7.1.1 Europe Parkinson’s Disease Drugs Sales by Country 7.1.2 Europe Parkinson’s Disease Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Parkinson’s Disease Drugs Market Facts & Figures by Type 7.3 Europe Parkinson’s Disease Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Parkinson’s Disease Drugs by Region 8.1.1 Asia Pacific Parkinson’s Disease Drugs Sales by Region 8.1.2 Asia Pacific Parkinson’s Disease Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Parkinson’s Disease Drugs Market Facts & Figures by Type 8.3 Asia Pacific Parkinson’s Disease Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Parkinson’s Disease Drugs by Country 9.1.1 Latin America Parkinson’s Disease Drugs Sales by Country 9.1.2 Latin America Parkinson’s Disease Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Parkinson’s Disease Drugs Market Facts & Figures by Type 9.3 Central & South America Parkinson’s Disease Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Parkinson’s Disease Drugs by Country 10.1.1 Middle East and Africa Parkinson’s Disease Drugs Sales by Country 10.1.2 Middle East and Africa Parkinson’s Disease Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Parkinson’s Disease Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Parkinson’s Disease Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 Novartis 11.1.1 Novartis Corporation Information 11.1.2 Novartis Description and Business Overview 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2021) 11.1.4 Novartis Parkinson’s Disease Drugs Products Offered 11.1.5 Novartis Related Developments 11.2 F. Hoffmann-La Roche 11.2.1 F. Hoffmann-La Roche Corporation Information 11.2.2 F. Hoffmann-La Roche Description and Business Overview 11.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2021) 11.2.4 F. Hoffmann-La Roche Parkinson’s Disease Drugs Products Offered 11.2.5 F. Hoffmann-La Roche Related Developments 11.3 AbbVie 11.3.1 AbbVie Corporation Information 11.3.2 AbbVie Description and Business Overview 11.3.3 AbbVie Sales, Revenue and Gross Margin (2015-2021) 11.3.4 AbbVie Parkinson’s Disease Drugs Products Offered 11.3.5 AbbVie Related Developments 11.4 Teva Pharmaceutical Industries 11.4.1 Teva Pharmaceutical Industries Corporation Information 11.4.2 Teva Pharmaceutical Industries Description and Business Overview 11.4.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2021) 11.4.4 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Products Offered 11.4.5 Teva Pharmaceutical Industries Related Developments 11.5 UCB Inc. 11.5.1 UCB Inc. Corporation Information 11.5.2 UCB Inc. Description and Business Overview 11.5.3 UCB Inc. Sales, Revenue and Gross Margin (2015-2021) 11.5.4 UCB Inc. Parkinson’s Disease Drugs Products Offered 11.5.5 UCB Inc. Related Developments 11.6 STADA Arzneimittel 11.6.1 STADA Arzneimittel Corporation Information 11.6.2 STADA Arzneimittel Description and Business Overview 11.6.3 STADA Arzneimittel Sales, Revenue and Gross Margin (2015-2021) 11.6.4 STADA Arzneimittel Parkinson’s Disease Drugs Products Offered 11.6.5 STADA Arzneimittel Related Developments 11.7 GlaxoSmithKline 11.7.1 GlaxoSmithKline Corporation Information 11.7.2 GlaxoSmithKline Description and Business Overview 11.7.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2021) 11.7.4 GlaxoSmithKline Parkinson’s Disease Drugs Products Offered 11.7.5 GlaxoSmithKline Related Developments 11.8 Bausch Health 11.8.1 Bausch Health Corporation Information 11.8.2 Bausch Health Description and Business Overview 11.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2021) 11.8.4 Bausch Health Parkinson’s Disease Drugs Products Offered 11.8.5 Bausch Health Related Developments 11.9 Merck 11.9.1 Merck Corporation Information 11.9.2 Merck Description and Business Overview 11.9.3 Merck Sales, Revenue and Gross Margin (2015-2021) 11.9.4 Merck Parkinson’s Disease Drugs Products Offered 11.9.5 Merck Related Developments 11.10 Impax Laboratories 11.10.1 Impax Laboratories Corporation Information 11.10.2 Impax Laboratories Description and Business Overview 11.10.3 Impax Laboratories Sales, Revenue and Gross Margin (2015-2021) 11.10.4 Impax Laboratories Parkinson’s Disease Drugs Products Offered 11.10.5 Impax Laboratories Related Developments 11.1 Novartis 11.1.1 Novartis Corporation Information 11.1.2 Novartis Description and Business Overview 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2021) 11.1.4 Novartis Parkinson’s Disease Drugs Products Offered 11.1.5 Novartis Related Developments 12 Future Forecast by Regions (Countries) (2021-2027) 12.1 Parkinson’s Disease Drugs Market Estimates and Projections by Region 12.1.1 Global Parkinson’s Disease Drugs Sales Forecast by Regions 2021-2027 12.1.2 Global Parkinson’s Disease Drugs Revenue Forecast by Regions 2021-2027 12.2 North America Parkinson’s Disease Drugs Market Size Forecast (2021-2027) 12.2.1 North America: Parkinson’s Disease Drugs Sales Forecast (2021-2027) 12.2.2 North America: Parkinson’s Disease Drugs Revenue Forecast (2021-2027) 12.2.3 North America: Parkinson’s Disease Drugs Market Size Forecast by Country (2021-2027) 12.3 Europe Parkinson’s Disease Drugs Market Size Forecast (2021-2027) 12.3.1 Europe: Parkinson’s Disease Drugs Sales Forecast (2021-2027) 12.3.2 Europe: Parkinson’s Disease Drugs Revenue Forecast (2021-2027) 12.3.3 Europe: Parkinson’s Disease Drugs Market Size Forecast by Country (2021-2027) 12.4 Asia Pacific Parkinson’s Disease Drugs Market Size Forecast (2021-2027) 12.4.1 Asia Pacific: Parkinson’s Disease Drugs Sales Forecast (2021-2027) 12.4.2 Asia Pacific: Parkinson’s Disease Drugs Revenue Forecast (2021-2027) 12.4.3 Asia Pacific: Parkinson’s Disease Drugs Market Size Forecast by Region (2021-2027) 12.5 Latin America Parkinson’s Disease Drugs Market Size Forecast (2021-2027) 12.5.1 Latin America: Parkinson’s Disease Drugs Sales Forecast (2021-2027) 12.5.2 Latin America: Parkinson’s Disease Drugs Revenue Forecast (2021-2027) 12.5.3 Latin America: Parkinson’s Disease Drugs Market Size Forecast by Country (2021-2027) 12.6 Middle East and Africa Parkinson’s Disease Drugs Market Size Forecast (2021-2027) 12.6.1 Middle East and Africa: Parkinson’s Disease Drugs Sales Forecast (2021-2027) 12.6.2 Middle East and Africa: Parkinson’s Disease Drugs Revenue Forecast (2021-2027) 12.6.3 Middle East and Africa: Parkinson’s Disease Drugs Market Size Forecast by Country (2021-2027) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Parkinson’s Disease Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Parkinson’s Disease Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Parkinson’s Disease Drugs Market Segments Table 2. Ranking of Global Top Parkinson’s Disease Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Parkinson’s Disease Drugs Market Size Growth Rate by Type 2021-2027 (K Units) & (US$ Million) Table 4. Major Manufacturers of Oral Table 5. Major Manufacturers of Transdermal Table 6. Major Manufacturers of Subcutaneous Table 7. Major Manufacturers of Intestinal Infusion Table 8. Global Parkinson’s Disease Drugs Market Size Growth Rate by Application 2021-2027 (K Units) Table 9. Global Parkinson’s Disease Drugs Market Size by Region (K Units) & (US$ Million): 2021 VS 2027 Table 10. Global Parkinson’s Disease Drugs Sales by Regions 2015-2021 (K Units) Table 11. Global Parkinson’s Disease Drugs Sales Market Share by Regions (2015-2021) Table 12. Global Parkinson’s Disease Drugs Revenue by Regions 2015-2021 (US$ Million) Table 13. Global Parkinson’s Disease Drugs Sales by Manufacturers (2015-2021) (K Units) Table 14. Global Parkinson’s Disease Drugs Sales Share by Manufacturers (2015-2021) Table 15. Global Parkinson’s Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2021) Table 16. Global Parkinson’s Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson’s Disease Drugs as of 2019) Table 17. Parkinson’s Disease Drugs Revenue by Manufacturers (2015-2021) (US$ Million) Table 18. Parkinson’s Disease Drugs Revenue Share by Manufacturers (2015-2021) Table 19. Key Manufacturers Parkinson’s Disease Drugs Price (2015-2021) (USD/Unit) Table 20. Parkinson’s Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Parkinson’s Disease Drugs Product Type Table 22. Date of International Manufacturers Enter into Parkinson’s Disease Drugs Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Parkinson’s Disease Drugs Sales by Type (2015-2021) (K Units) Table 25. Global Parkinson’s Disease Drugs Sales Share by Type (2015-2021) Table 26. Global Parkinson’s Disease Drugs Revenue by Type (2015-2021) (US$ Million) Table 27. Global Parkinson’s Disease Drugs Revenue Share by Type (2015-2021) Table 28. Parkinson’s Disease Drugs Average Selling Price (ASP) by Type 2015-2021 (USD/Unit) Table 29. Global Parkinson’s Disease Drugs Sales by Application (2015-2021) (K Units) Table 30. Global Parkinson’s Disease Drugs Sales Share by Application (2015-2021) Table 31. North America Parkinson’s Disease Drugs Sales by Country (2015-2021) (K Units) Table 32. North America Parkinson’s Disease Drugs Sales Market Share by Country (2015-2021) Table 33. North America Parkinson’s Disease Drugs Revenue by Country (2015-2021) (US$ Million) Table 34. North America Parkinson’s Disease Drugs Revenue Market Share by Country (2015-2021) Table 35. North America Parkinson’s Disease Drugs Sales by Type (2015-2021) (K Units) Table 36. North America Parkinson’s Disease Drugs Sales Market Share by Type (2015-2021) Table 37. North America Parkinson’s Disease Drugs Sales by Application (2015-2021) (K Units) Table 38. North America Parkinson’s Disease Drugs Sales Market Share by Application (2015-2021) Table 39. Europe Parkinson’s Disease Drugs Sales by Country (2015-2021) (K Units) Table 40. Europe Parkinson’s Disease Drugs Sales Market Share by Country (2015-2021) Table 41. Europe Parkinson’s Disease Drugs Revenue by Country (2015-2021) (US$ Million) Table 42. Europe Parkinson’s Disease Drugs Revenue Market Share by Country (2015-2021) Table 43. Europe Parkinson’s Disease Drugs Sales by Type (2015-2021) (K Units) Table 44. Europe Parkinson’s Disease Drugs Sales Market Share by Type (2015-2021) Table 45. Europe Parkinson’s Disease Drugs Sales by Application (2015-2021) (K Units) Table 46. Europe Parkinson’s Disease Drugs Sales Market Share by Application (2015-2021) Table 47. Asia Pacific Parkinson’s Disease Drugs Sales by Region (2015-2021) (K Units) Table 48. Asia Pacific Parkinson’s Disease Drugs Sales Market Share by Region (2015-2021) Table 49. Asia Pacific Parkinson’s Disease Drugs Revenue by Region (2015-2021) (US$ Million) Table 50. Asia Pacific Parkinson’s Disease Drugs Revenue Market Share by Region (2015-2021) Table 51. Asia Pacific Parkinson’s Disease Drugs Sales by Type (2015-2021) (K Units) Table 52. Asia Pacific Parkinson’s Disease Drugs Sales Market Share by Type (2015-2021) Table 53. Asia Pacific Parkinson’s Disease Drugs Sales by Application (2015-2021) (K Units) Table 54. Asia Pacific Parkinson’s Disease Drugs Sales Market Share by Application (2015-2021) Table 55. Latin America Parkinson’s Disease Drugs Sales by Country (2015-2021) (K Units) Table 56. Latin America Parkinson’s Disease Drugs Sales Market Share by Country (2015-2021) Table 57. Latin Americaa Parkinson’s Disease Drugs Revenue by Country (2015-2021) (US$ Million) Table 58. Latin America Parkinson’s Disease Drugs Revenue Market Share by Country (2015-2021) Table 59. Latin America Parkinson’s Disease Drugs Sales by Type (2015-2021) (K Units) Table 60. Latin America Parkinson’s Disease Drugs Sales Market Share by Type (2015-2021) Table 61. Latin America Parkinson’s Disease Drugs Sales by Application (2015-2021) (K Units) Table 62. Latin America Parkinson’s Disease Drugs Sales Market Share by Application (2015-2021) Table 63. Middle East and Africa Parkinson’s Disease Drugs Sales by Country (2015-2021) (K Units) Table 64. Middle East and Africa Parkinson’s Disease Drugs Sales Market Share by Country (2015-2021) Table 65. Middle East and Africa Parkinson’s Disease Drugs Revenue by Country (2015-2021) (US$ Million) Table 66. Middle East and Africa Parkinson’s Disease Drugs Revenue Market Share by Country (2015-2021) Table 67. Middle East and Africa Parkinson’s Disease Drugs Sales by Type (2015-2021) (K Units) Table 68. Middle East and Africa Parkinson’s Disease Drugs Sales Market Share by Type (2015-2021) Table 69. Middle East and Africa Parkinson’s Disease Drugs Sales by Application (2015-2021) (K Units) Table 70. Middle East and Africa Parkinson’s Disease Drugs Sales Market Share by Application (2015-2021) Table 71. Novartis Corporation Information Table 72. Novartis Description and Major Businesses Table 73. Novartis Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 74. Novartis Product Table 75. Novartis Recent Development Table 76. F. Hoffmann-La Roche Corporation Information Table 77. F. Hoffmann-La Roche Description and Major Businesses Table 78. F. Hoffmann-La Roche Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 79. F. Hoffmann-La Roche Product Table 80. F. Hoffmann-La Roche Recent Development Table 81. AbbVie Corporation Information Table 82. AbbVie Description and Major Businesses Table 83. AbbVie Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 84. AbbVie Product Table 85. AbbVie Recent Development Table 86. Teva Pharmaceutical Industries Corporation Information Table 87. Teva Pharmaceutical Industries Description and Major Businesses Table 88. Teva Pharmaceutical Industries Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 89. Teva Pharmaceutical Industries Product Table 90. Teva Pharmaceutical Industries Recent Development Table 91. UCB Inc. Corporation Information Table 92. UCB Inc. Description and Major Businesses Table 93. UCB Inc. Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 94. UCB Inc. Product Table 95. UCB Inc. Recent Development Table 96. STADA Arzneimittel Corporation Information Table 97. STADA Arzneimittel Description and Major Businesses Table 98. STADA Arzneimittel Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 99. STADA Arzneimittel Product Table 100. STADA Arzneimittel Recent Development Table 101. GlaxoSmithKline Corporation Information Table 102. GlaxoSmithKline Description and Major Businesses Table 103. GlaxoSmithKline Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 104. GlaxoSmithKline Product Table 105. GlaxoSmithKline Recent Development Table 106. Bausch Health Corporation Information Table 107. Bausch Health Description and Major Businesses Table 108. Bausch Health Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 109. Bausch Health Product Table 110. Bausch Health Recent Development Table 111. Merck Corporation Information Table 112. Merck Description and Major Businesses Table 113. Merck Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 114. Merck Product Table 115. Merck Recent Development Table 116. Impax Laboratories Corporation Information Table 117. Impax Laboratories Description and Major Businesses Table 118. Impax Laboratories Parkinson’s Disease Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2021) Table 119. Impax Laboratories Product Table 120. Impax Laboratories Recent Development Table 121. Global Parkinson’s Disease Drugs Sales Forecast by Regions (2021-2027) (K Units) Table 122. Global Parkinson’s Disease Drugs Sales Market Share Forecast by Regions (2021-2027) Table 123. Global Parkinson’s Disease Drugs Revenue Forecast by Regions (2021-2027) (US$ Million) Table 124. Global Parkinson’s Disease Drugs Revenue Market Share Forecast by Regions (2021-2027) Table 125. North America: Parkinson’s Disease Drugs Sales Forecast by Country (2021-2027) (K Units) Table 126. North America: Parkinson’s Disease Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 127. Europe: Parkinson’s Disease Drugs Sales Forecast by Country (2021-2027) (K Units) Table 128. Europe: Parkinson’s Disease Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 129. Asia Pacific: Parkinson’s Disease Drugs Sales Forecast by Region (2021-2027) (K Units) Table 130. Asia Pacific: Parkinson’s Disease Drugs Revenue Forecast by Region (2021-2027) (US$ Million) Table 131. Latin America: Parkinson’s Disease Drugs Sales Forecast by Country (2021-2027) (K Units) Table 132. Latin America: Parkinson’s Disease Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 133. Middle East and Africa: Parkinson’s Disease Drugs Sales Forecast by Country (2021-2027) (K Units) Table 134. Middle East and Africa: Parkinson’s Disease Drugs Revenue Forecast by Country (2021-2027) (US$ Million) Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2027) Table 136. Key Challenges Table 137. Market Risks Table 138. Main Points Interviewed from Key Parkinson’s Disease Drugs Players Table 139. Parkinson’s Disease Drugs Customers List Table 140. Parkinson’s Disease Drugs Distributors List Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Parkinson’s Disease Drugs Product Picture Figure 2. Global Parkinson’s Disease Drugs Sales Market Share by Type in 2021 & 2027 Figure 3. Oral Product Picture Figure 4. Transdermal Product Picture Figure 5. Subcutaneous Product Picture Figure 6. Intestinal Infusion Product Picture Figure 7. Global Parkinson’s Disease Drugs Sales Market Share by Application in 2021 & 2027 Figure 8. Hospital Pharmacy Figure 9. Retail Pharmacy Figure 10. Online Pharmacy Figure 11. Parkinson’s Disease Drugs Report Years Considered Figure 12. Global Parkinson’s Disease Drugs Market Size 2015-2027 (US$ Million) Figure 13. Global Parkinson’s Disease Drugs Sales 2015-2027 (K Units) Figure 14. Global Parkinson’s Disease Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Parkinson’s Disease Drugs Sales Market Share by Region (2015-2021) Figure 16. Global Parkinson’s Disease Drugs Sales Market Share by Region in 2019 Figure 17. Global Parkinson’s Disease Drugs Revenue Market Share by Region (2015-2021) Figure 18. Global Parkinson’s Disease Drugs Revenue Market Share by Region in 2019 Figure 19. Global Parkinson’s Disease Drugs Sales Share by Manufacturer in 2019 Figure 20. The Top 10 and 5 Players Market Share by Parkinson’s Disease Drugs Revenue in 2019 Figure 21. Parkinson’s Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. Global Parkinson’s Disease Drugs Sales Market Share by Type (2015-2021) Figure 23. Global Parkinson’s Disease Drugs Sales Market Share by Type in 2019 Figure 24. Global Parkinson’s Disease Drugs Revenue Market Share by Type (2015-2021) Figure 25. Global Parkinson’s Disease Drugs Revenue Market Share by Type in 2019 Figure 26. Global Parkinson’s Disease Drugs Market Share by Price Range (2015-2021) Figure 27. Global Parkinson’s Disease Drugs Sales Market Share by Application (2015-2021) Figure 28. Global Parkinson’s Disease Drugs Sales Market Share by Application in 2019 Figure 29. Global Parkinson’s Disease Drugs Revenue Market Share by Application (2015-2021) Figure 30. Global Parkinson’s Disease Drugs Revenue Market Share by Application in 2019 Figure 31. North America Parkinson’s Disease Drugs Sales Growth Rate 2015-2021 (K Units) Figure 32. North America Parkinson’s Disease Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 33. North America Parkinson’s Disease Drugs Sales Market Share by Country in 2019 Figure 34. North America Parkinson’s Disease Drugs Revenue Market Share by Country in 2019 Figure 35. U.S. Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 36. U.S. Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 37. Canada Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 38. Canada Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 39. North America Parkinson’s Disease Drugs Market Share by Type in 2019 Figure 40. North America Parkinson’s Disease Drugs Market Share by Application in 2019 Figure 41. Europe Parkinson’s Disease Drugs Sales Growth Rate 2015-2021 (K Units) Figure 42. Europe Parkinson’s Disease Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 43. Europe Parkinson’s Disease Drugs Sales Market Share by Country in 2019 Figure 44. Europe Parkinson’s Disease Drugs Revenue Market Share by Country in 2019 Figure 45. Germany Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 46. Germany Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 47. France Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 48. France Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 49. U.K. Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 50. U.K. Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 51. Italy Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 52. Italy Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 53. Russia Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 54. Russia Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 55. Europe Parkinson’s Disease Drugs Market Share by Type in 2019 Figure 56. Europe Parkinson’s Disease Drugs Market Share by Application in 2019 Figure 57. Asia Pacific Parkinson’s Disease Drugs Sales Growth Rate 2015-2021 (K Units) Figure 58. Asia Pacific Parkinson’s Disease Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 59. Asia Pacific Parkinson’s Disease Drugs Sales Market Share by Region in 2019 Figure 60. Asia Pacific Parkinson’s Disease Drugs Revenue Market Share by Region in 2019 Figure 61. China Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 62. China Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 63. Japan Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 64. Japan Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 65. South Korea Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 66. South Korea Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 67. India Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 68. India Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 69. Australia Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 70. Australia Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 71. Taiwan Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 72. Taiwan Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 73. Indonesia Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 74. Indonesia Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 75. Thailand Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 76. Thailand Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 77. Malaysia Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 78. Malaysia Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 79. Philippines Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 80. Philippines Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 81. Vietnam Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 82. Vietnam Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 83. Asia Pacific Parkinson’s Disease Drugs Market Share by Type in 2019 Figure 84. Asia Pacific Parkinson’s Disease Drugs Market Share by Application in 2019 Figure 85. Latin America Parkinson’s Disease Drugs Sales Growth Rate 2015-2021 (K Units) Figure 86. Latin America Parkinson’s Disease Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 87. Latin America Parkinson’s Disease Drugs Sales Market Share by Country in 2019 Figure 88. Latin America Parkinson’s Disease Drugs Revenue Market Share by Country in 2019 Figure 89. Mexico Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 90. Mexico Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 91. Brazil Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 92. Brazil Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 93. Argentina Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 94. Argentina Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 95. Latin America Parkinson’s Disease Drugs Market Share by Type in 2019 Figure 96. Latin America Parkinson’s Disease Drugs Market Share by Application in 2019 Figure 97. Middle East and Africa Parkinson’s Disease Drugs Sales Growth Rate 2015-2021 (K Units) Figure 98. Middle East and Africa Parkinson’s Disease Drugs Revenue Growth Rate 2015-2021 (US$ Million) Figure 99. Middle East and Africa Parkinson’s Disease Drugs Sales Market Share by Country in 2019 Figure 100. Middle East and Africa Parkinson’s Disease Drugs Revenue Market Share by Country in 2019 Figure 101. Turkey Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 102. Turkey Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 103. Saudi Arabia Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 104. Saudi Arabia Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 105. U.A.E Parkinson’s Disease Drugs Sales Growth Rate (2015-2021) (K Units) Figure 106. U.A.E Parkinson’s Disease Drugs Revenue Growth Rate (2015-2021) (US$ Million) Figure 107. Middle East and Africa Parkinson’s Disease Drugs Market Share by Type in 2019 Figure 108. Middle East and Africa Parkinson’s Disease Drugs Market Share by Application in 2019 Figure 109. North America Parkinson’s Disease Drugs Sales Growth Rate Forecast (2021-2027) (K Units) Figure 110. North America Parkinson’s Disease Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 111. Europe Parkinson’s Disease Drugs Sales Growth Rate Forecast (2021-2027) (K Units) Figure 112. Europe Parkinson’s Disease Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 113. Asia Pacific Parkinson’s Disease Drugs Sales Growth Rate Forecast (2021-2027) (K Units) Figure 114. Asia Pacific Parkinson’s Disease Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 115. Latin America Parkinson’s Disease Drugs Sales Growth Rate Forecast (2021-2027) (K Units) Figure 116. Latin America Parkinson’s Disease Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 117. Middle East and Africa Parkinson’s Disease Drugs Sales Growth Rate Forecast (2021-2027) (K Units) Figure 118. Middle East and Africa Parkinson’s Disease Drugs Revenue Growth Rate Forecast (2021-2027) (US$ Million) Figure 119. Porter's Five Forces Analysis Figure 120. Channels of Distribution Figure 121. Distributors Profiles Figure 122. Bottom-up and Top-down Approaches for This Report Figure 123. Data Triangulation Figure 124. Key Executives Interviewed

Get Free Sample

Related Reports

Global Parkinson’s Disease Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Parkinson’s Disease Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Parkinson’s Disease Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Parkinson’s Disease Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Parkinson’s Disease Drugs Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)